Anti-Platelet Agents Interactions

Concomitant treatment with other GP IIb/IIIa inhibitors should be avoided.

Source: NLP:eptifibatide

PYRUKYND may affect P-gp substrates with narrow therapeutic index. Avoid concomitant use.

Source: NLP:mitapivat

Apalutamide induces P-glycoprotein and decreases exposure of P-gp substrates, which may decrease their effectiveness. Consider alternative agents or monitor for loss of activity.

Source: NLP:apalutamide

Omega-3-acid ethyl esters may prolong bleeding time. Patients receiving both should be monitored periodically.

Source: NLP:omega-3-acid ethyl esters

Omega-3-acid ethyl esters may prolong bleeding time. Patients taking concomitant anti-platelet agents should be monitored periodically.

Source: NLP:omega-3-acid ethyl esters capsules

Bleeding reported in patients treated with pentoxifylline with concomitant platelet aggregation inhibitors.

Source: NLP:pentoxifylline

Safety and effectiveness of argatroban with glycoprotein IIb/IIIa antagonists have not been established.

Source: NLP:argatroban